This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular edema, a large-scale analysis of electronic medical records revealed.
Medscape Medical News